Wakamiya H, Suzuki E, Yamamoto I, Akiba M, Arakawa N
Division of Human Science and Technology, Ochanomizu University, Tokyo, Japan.
J Nutr Sci Vitaminol (Tokyo). 1995 Apr;41(2):265-72. doi: 10.3177/jnsv.41.265.
The intestinal absorption efficacy of 2-O-alpha-D-glucopyranosyl-L-ascorbic acid (AA-2G), which has been recently synthesized and characterized as a stable ascorbate (AsA), was determined in guinea pigs by the perfusion technique. Perfusion of AA-2G in isotonic phosphate buffer to the small intestine resulted in a decrease of AA-2G accompanied by an increase of AsA in the perfusate. The results showed that intact AA-2G was not detected in the plasma of the portal vein of guinea pigs at 2 h after perfusion. The disappearance of AA-2G from perfusate was completely inhibited by the addition of castanospermine, a specific alpha-glucosidase inhibitor, or by carbohydrates such as maltose. These results indicate that ascorbic acid released from AA-2G by alpha-glucosidase on the brush border membrane is effectively taken up across the intestinal ascorbate transport channels, into a serosal site, whereas AA-2G permeation was poor via the passive transport system.
最近合成并被鉴定为一种稳定抗坏血酸盐(AsA)的2-O-α-D-吡喃葡萄糖基-L-抗坏血酸(AA-2G),其肠道吸收功效在豚鼠中通过灌注技术得以测定。将等渗磷酸盐缓冲液中的AA-2G灌注到小肠中,导致AA-2G减少,同时灌注液中AsA增加。结果表明,灌注后2小时在豚鼠门静脉血浆中未检测到完整的AA-2G。添加特异性α-葡萄糖苷酶抑制剂栗精胺或麦芽糖等碳水化合物可完全抑制灌注液中AA-2G的消失。这些结果表明,刷状缘膜上的α-葡萄糖苷酶从AA-2G释放的抗坏血酸通过肠道抗坏血酸盐转运通道有效地吸收进入浆膜部位,而AA-2G通过被动转运系统的渗透较差。